Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease

Summary

Study to measure the continued effectiveness of apomorphine after previous exposure of at least three months duration.

Timeline

Start

2001-07

Primary completion

—

Completion

2002-06

Drugs

Indications